683 Capital Management »

Pyxis Oncology shares owned by 683 Capital Management

Quarter-by-quarter ownership of Pyxis Oncology (PYXS) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Pyxis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Pyxis Oncology held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pyxis Oncology by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.2M 525k 2.22
2025-06-30 $600k 545k 1.10
2025-03-31 $539k 550k 0.98
2024-12-31 $647k 415k 1.56
2024-09-30 $1.5M 415k 3.67

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. (LLY)
Tesla Motors Put Option (TSLA)
Capital One Financial (COF)
Madrigal Pharmaceuticals Put Option (MDGL)
Uniqure Nv SHS (QURE)
Alnylam Pharmaceuticals Put Option (ALNY)
Carvana Cl A (CVNA)
Insmed Com Par $.01 Put Option (INSM)
Uwm Holdings Corporation Com Cl A (UWMC)
Strategy Cl A New Put Option (MSTR)
Gxo Logistics Incorporated Common Stock (GXO)
Western Digital (WDC)
Novo-nordisk A S Adr Put Option (NVO)
United Therapeutics Corporation Put Option (UTHR)

View all positions for 683 Capital Management

Top funds holding Pyxis Oncology

Pfizer
Laurion Capital Management
Tang Capital Management
Vanguard Group
Perceptive Advisors
Palo Alto Investors
Millennium Management
Stempoint Capital
BlackRock
Renaissance Technologies
Geode Capital Management
683 Capital Management
Driehaus Capital Management
UBS Group
Citadel Advisors

View all funds holding Pyxis Oncology